Evidence map›Paper›PMID 26939524›Full record

ArticleBMC veterinary research2016

In vitro antimicrosporidial activity of gold nanoparticles against Heterosporis saurida.

Mona Saleh, Gokhlesh Kumar, Abdel-Azeem Abdel-Baki, Saleh Al-Quraishy, Mansour El-Matbouli

Abstract read
In one paragraph

Article in BMC veterinary research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mona SalehClinical Division of Fish Medicine, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. mona.saleh@vetmeduni.ac.at.
Gokhlesh KumarClinical Division of Fish Medicine, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. gokhlesh.kumar@vetmeduni.ac.at.
Abdel-Azeem Abdel-BakiZoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia. azema1@yahoo.com.
Saleh Al-QuraishyZoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia. guraishi@yahoo.com.
Mansour El-MatbouliClinical Division of Fish Medicine, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. Mansour.El-Matbouli@vetmeduni.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWorldwide, there is a need to expand the number of drugs available to treat parasitic infections in aquaculture. One of the new materials being tested is metal nanoparticles, which have unique chemical and physical characteristics owing to their extremely small size and high surface area to volume ratio. We examined the effectiveness of gold nanoparticles against the microsporidian parasite Heterosporis saurida, which causes severe economic losses in lizard fish, Saurida undosquamis aquaculture.

resultsWe synthesized gold nanoparticles by chemical reduction of tetrachloroauric acid as a metal precursor. We assessed the antimicrosporidial efficacy of the nanoparticles against H. saurida using an in vitro screening approach, which we had developed previously using the eel kidney cell line EK-1. The number of H. saurida spores produced in EK-1 cells was reduced in a proportional manner to the dosage of gold nanoparticles administered. A cell metabolic activity test (MTT) indicated that the gold nanoparticles did not appear to be toxic to the host cells.

conclusionsGold nanoparticles can act as an effective antimicrosporidial agent and hold promise to reduce disease in lizardfish aquaculture. Metal nanoparticles should be considered as an alternate choice for development of new antimicrosporidial drugs to combat disease problems in aquaculture.

Indexed as

GoldMicrosporidaAnimalsFish DiseasesFishesMetal NanoparticlesMicrosporidiosisGold

Identifiers

PMID26939524
PMCPMC4778277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.